Autism Spectrum Disorders and Psychiatry: Update on Diagnostic and Treatment Considerations

This activity offers CE credits for: 1. Physicians (CME) 2. Other ACTIVITY GOAL The focus of this article is on diagnostic and treatment considerations in autism spectrum disorder (ASD). LEARNING OBJECTIVES At the end of this CE activity, participants should be able to: • Determine best assessment practices for ASD during the developmental stages of early childhood, middle childhood, adolescence, and adulthood • Identify the differential diagnoses for each developmental stage • Decide which interventions are best suited for each particular patient TARGET AUDIENCE This continuing medical education activity is intended for psychiatrists, psychologists, primary care physicians, physician assistants, nurse practitioners, and other health care professionals who seek to improve their care for patients with mental health disorders. CREDIT INFORMATION CME Credit (Physicians): This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of CME Outfitters, LLC, and Psychiatric Times. CME Outfitters, LLC, is accredited by the ACCME to provide continuing medical education for physicians. CME Outfitters designates this enduring material for a maximum of 1.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Note to Nurse Practitioners and Physician Assistants: AANPCP and AAPA accept certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM. DISCLOSURE DECLARATION It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer-review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations. Jennifer Foss-Feig, PhD, has no disclosures to report. James McPartland, PhD, reports that he was a co-investigator on a Janssen clinical trial. Fred Volkmar, MD, (peer/content reviewer) has no disclosures to report. Applicable Psychiatric Times staff and CME Outfitters staff have no disclosures to report. UNLABELED USE DISCLOSURE Faculty of this CME/CE activity may include discussion of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the